Black Rock Inc. Arcus Biosciences, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 9,763,113 shares of RCUS stock, worth $155 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,763,113

Previous 9,900,341 1.39%

Holding current value

$155 Million

Previous $187 Million 20.45%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$14.59 - $18.48 $2 Million - $2.54 Million	-137,228 Reduced 1.39%	9,763,113 $149 Million
Q1 2024 May 10, 2024	SELL	$14.83 - $20.18 $2 Million - $2.72 Million	-134,829 Reduced 1.34%	9,900,341 $187 Million
Q4 2023 Feb 13, 2024	BUY	$13.43 - $19.63 $5.59 Million - $8.17 Million	416,343 Added 4.33%	10,035,170 $192 Million
Q3 2023 Nov 13, 2023	BUY	$17.62 - $23.54 $2.59 Million - $3.46 Million	146,790 Added 1.55%	9,618,827 $173 Million
Q2 2023 Aug 11, 2023	SELL	$16.97 - $22.03 $11.3 Million - $14.7 Million	-666,983 Reduced 6.58%	9,472,037 $192 Million
Q1 2023 May 12, 2023	BUY	$15.96 - $23.15 $12 Million - $17.4 Million	749,972 Added 7.99%	10,139,020 $185 Million
Q4 2022 Feb 13, 2023	BUY	$19.7 - $35.71 $9.08 Million - $16.5 Million	460,820 Added 5.16%	9,389,048 $194 Million
Q3 2022 Nov 14, 2022	BUY	$23.23 - $30.07 $18.7 Million - $24.2 Million	805,534 Added 9.92%	8,928,228 $234 Million
Q2 2022 Aug 12, 2022	BUY	$17.23 - $37.73 $68.6 Million - $150 Million	3,983,168 Added 96.22%	8,122,694 $206 Million
Q1 2022 May 12, 2022	BUY	$28.92 - $41.83 $277,545 - $401,442	9,597 Added 0.23%	4,139,526 $131 Million
Q4 2021 Feb 10, 2022	SELL	$31.38 - $48.47 $2.29 Million - $3.54 Million	-73,031 Reduced 1.74%	4,129,929 $167 Million
Q3 2021 Nov 09, 2021	BUY	$26.93 - $37.68 $4.42 Million - $6.19 Million	164,232 Added 4.07%	4,202,960 $147 Million
Q2 2021 Aug 11, 2021	BUY	$22.75 - $35.77 $91.9 Million - $144 Million	4,038,728 New	4,038,728 $111 Million

Others Institutions Holding RCUS

# of Institutions

200

Shares Held

51.5M

Call Options Held

236K

Put Options Held

141K

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.15B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account